Home » Topics » Regulatory

Regulatory
RSS

Minocycline superior to placebo for early RA

June 25, 1997

Pulmicort Turbuhaler approved by FDA

June 25, 1997

Combination therapy approved by FDA for H. pylori eradication

June 20, 1997

Coreg now available in the U.S. for heart failure

June 18, 1997

DuPont Merck's breast imaging agent approved in the U.K.

June 18, 1997

RPR seeks approval for enoxaparin for unstable angina in Europe

June 18, 1997

New vial size of generic leucovorin approved by FDA

June 17, 1997

Botulinum toxin type A evaluated in cerebral palsy

June 16, 1997

Oral human immunoglobulin enters clinic for severe RA

June 13, 1997

Testosterone transdermal patch now available in the U.S. in a once-daily formulation

June 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...